Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $776.59 million. The enterprise value is $545.22 million.
| Market Cap | 776.59M |
| Enterprise Value | 545.22M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 143.02 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Shares Outstanding | 143.02M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 7.07% |
| Owned by Institutions (%) | 40.33% |
| Float | 127.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 37.58 |
| PS Ratio | 4.06 |
| Forward PS | 4.28 |
| PB Ratio | 2.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61, with a Debt / Equity ratio of 0.25.
| Current Ratio | 5.61 |
| Quick Ratio | 4.91 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.21 |
Financial Efficiency
Return on equity (ROE) is -16.40% and return on invested capital (ROIC) is -16.82%.
| Return on Equity (ROE) | -16.40% |
| Return on Assets (ROA) | -11.50% |
| Return on Capital (ROIC) | -16.82% |
| Revenue Per Employee | $638,023 |
| Profits Per Employee | -$208,543 |
| Employee Count | 300 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.60 |
Taxes
In the past 12 months, AUPH has paid $854,000 in taxes.
| Income Tax | 854,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.65% in the last 52 weeks. The beta is 1.42, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -45.65% |
| 50-Day Moving Average | 5.34 |
| 200-Day Moving Average | 6.83 |
| Relative Strength Index (RSI) | 48.77 |
| Average Volume (20 Days) | 1,129,708 |
Short Selling Information
The latest short interest is 10.18 million, so 7.12% of the outstanding shares have been sold short.
| Short Interest | 10.18M |
| Short Previous Month | 9.21M |
| Short % of Shares Out | 7.12% |
| Short % of Float | 8.01% |
| Short Ratio (days to cover) | 7.75 |
Income Statement
In the last 12 months, AUPH had revenue of $191.41 million and -$62.56 million in losses. Loss per share was -$0.42.
| Revenue | 191.41M |
| Gross Profit | 169.93M |
| Operating Income | -75.36M |
| Pretax Income | -61.71M |
| Net Income | -62.56M |
| EBITDA | -41.87M |
| EBIT | -57.65M |
| Loss Per Share | -$0.42 |
Balance Sheet
The company has $319.91 million in cash and $88.54 million in debt, giving a net cash position of $231.38 million or $1.62 per share.
| Cash & Cash Equivalents | 319.91M |
| Total Debt | 88.54M |
| Net Cash | 231.38M |
| Net Cash Per Share | $1.62 |
| Equity (Book Value) | 359.48M |
| Book Value Per Share | 2.51 |
| Working Capital | 327.17M |
Cash Flow
In the last 12 months, operating cash flow was -$20.39 million and capital expenditures -$221,000, giving a free cash flow of -$20.61 million.
| Operating Cash Flow | -20.39M |
| Capital Expenditures | -221,000 |
| Free Cash Flow | -20.61M |
| FCF Per Share | -$0.14 |
Margins
Gross margin is 88.78%, with operating and profit margins of -39.37% and -32.69%.
| Gross Margin | 88.78% |
| Operating Margin | -39.37% |
| Pretax Margin | -32.24% |
| Profit Margin | -32.69% |
| EBITDA Margin | -21.88% |
| EBIT Margin | -30.12% |
| FCF Margin | -10.77% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | -0.96% |
| Earnings Yield | -8.06% |
| FCF Yield | -2.65% |
Analyst Forecast
The average price target for AUPH is $10.33, which is 90.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.33 |
| Price Target Difference | 90.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 21.78% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 1.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.14 |
| Piotroski F-Score | 2 |